Family main features
CDA1 (Cell Division Autoantigen 1), also known as TSPYL2 (Testis-Specific Y-Like Protein 2), is a multifunctional nuclear protein involved in the regulation of cell growth, division, and differentiation. Originally identified as an autoantigen in patients with systemic lupus erythematosus (SLE), CDA1 has emerged as a significant player in several cellular processes, including tumor suppression, response to DNA damage, and modulation of TGF-β signaling.
CDA1 is expressed in a wide range of tissues, particularly in the brain, liver, and reproductive organs. Its activity is regulated at multiple levels, including transcriptional, post-transcriptional, and post-translational modifications. The protein's involvement in key cellular pathways highlights its potential role in cancer biology, neurodevelopment, and autoimmune diseases.
One of the most notable functions of CDA1 is its ability to regulate the transforming growth factor-beta (TGF-β) signaling pathway, a critical pathway involved in tissue fibrosis, cellular proliferation, and differentiation. Dysregulation of CDA1 has been linked to various pathological conditions, such as fibrotic diseases, cancer progression, and neurological disorders. As a result, CDA1 has garnered increasing attention in biomedical research due to its potential therapeutic implications.
CDA1 is encoded by the TSPYL2 gene, which is located on chromosome Xp11.22 in humans. The protein is approximately 500-600 amino acids in length, depending on the specific isoform, and has a molecular weight of around 65-70 kDa. It is classified as a member of the TSPY (Testis-Specific Protein Y-encoded)-like protein family, which contains several proteins with roles in chromatin remodeling, gene expression regulation, and cell cycle control.
The CDA1 protein is composed of several distinct domains that contribute to its functional diversity. Key features of the CDA1 protein include:
CDA1 adopts a globular tertiary structure stabilized by several α-helices and β-sheets. The TSPY-like domain forms a core structural motif essential for its interactions with chromatin and other nuclear proteins. Despite its relatively compact structure, CDA1 exhibits a degree of flexibility that allows it to engage in various signaling pathways through protein-protein interactions. The leucine-rich motifs contribute to protein dimerization, which may further modulate its activity by increasing its affinity for certain DNA regions or transcriptional complexes.
CDA1 undergoes multiple post-translational modifications that regulate its activity, including:
CDA1 is part of the TSPY-like protein family, a group of proteins that are involved in cell growth regulation, chromatin dynamics, and tumor suppression. Although no distinct isoforms or subtypes of CDA1 have been extensively characterized, the protein exists in multiple tissues with potential post-transcriptional and post-translational modifications that may influence its activity in different cellular contexts.
Given its role in cell cycle regulation, TGF-β signaling, and chromatin dynamics, CDA1 is functionally classified as both a transcriptional regulator and a cell cycle modulator. The protein's activities in different tissues and cell types are likely context-dependent, contributing to its diverse range of biological effects.
CDA1 plays a pivotal role in several key biological processes, including:
CDA1 is a negative regulator of cell proliferation, primarily through its ability to interact with and modulate key cell cycle regulators. It inhibits the transition from the G1 to the S phase, thereby controlling cell division. This function is particularly important in maintaining normal tissue homeostasis and preventing uncontrolled cell proliferation, which can lead to tumorigenesis.
One of the most significant functions of CDA1 is its interaction with the TGF-β pathway. TGF-β is a multifunctional cytokine that plays critical roles in cell growth, differentiation, apoptosis, and fibrosis. CDA1 enhances the transcriptional activity of Smad proteins, the intracellular mediators of TGF-β signaling, thereby amplifying the effects of TGF-β on target genes. This function of CDA1 is particularly important in fibrotic diseases, where excessive TGF-β signaling leads to the deposition of extracellular matrix components and tissue scarring.
CDA1 has been implicated in chromatin remodeling through its interaction with histone-modifying enzymes and chromatin-binding proteins. By modulating chromatin accessibility, CDA1 influences the transcription of genes involved in cell proliferation, DNA repair, and stress responses. This function is crucial in maintaining genomic stability and preventing the accumulation of DNA damage.
CDA1 is regarded as a potential tumor suppressor due to its ability to inhibit cell proliferation and promote cell cycle arrest. In several cancer models, overexpression of CDA1 has been shown to reduce tumor growth, while loss of CDA1 function is associated with increased tumorigenesis and poor prognosis. This suggests that CDA1 may play a protective role in preventing the initiation and progression of certain cancers.
Given its role in TGF-β signaling, CDA1 is implicated in the pathogenesis of fibrotic diseases, including liver fibrosis, pulmonary fibrosis, and kidney fibrosis. In these conditions, CDA1 amplifies the pro-fibrotic effects of TGF-β, leading to excessive extracellular matrix deposition and tissue scarring. Targeting CDA1 or modulating its activity represents a potential therapeutic strategy for treating fibrotic disorders.
CDA1’s role as a tumor suppressor suggests that it may be a target for cancer therapy. Loss of CDA1 expression or function has been observed in several types of cancer, including breast cancer, lung cancer, and gliomas. In these cancers, reduced CDA1 activity is associated with increased proliferation, metastasis, and resistance to apoptosis. Restoring CDA1 activity or enhancing its tumor-suppressive functions may provide a therapeutic benefit in treating these malignancies.
CDA1 is highly expressed in the brain, particularly in regions involved in neurodevelopment and cognitive function. Its precise role in the nervous system is still under investigation, but studies suggest that CDA1 may be involved in the regulation of neuronal differentiation and synaptic plasticity. Dysregulation of CDA1 has been linked to neurodevelopmental disorders, and further research is needed to explore its potential involvement in conditions such as autism and intellectual disability.
CDA1 (Cell Division Autoantigen 1), also known as TSPYL2, is a multifunctional protein with roles in cell cycle regulation, transcriptional control, and modulation of TGF-β signaling. Structurally, CDA1 features a TSPY-like domain and multiple post-translational modifications, such as phosphorylation and ubiquitination, which regulate its activity. CDA1 functions as a tumor suppressor by inhibiting cell proliferation and promoting cell cycle arrest, and it also plays a critical role in fibrotic diseases by amplifying TGF-β signaling. Clinically, CDA1 has been linked to cancer, fibrotic disorders, and potentially neurodevelopmental diseases. Its involvement in these processes makes it an important target for therapeutic interventions, with potential applications in treating fibrosis, cancer, and other diseases associated with TGF-β dysregulation.
CD1a molecule (CD1A)
R4,T6,CD1,FCB6,HTA1,T-cell surface glycoprotein CD1a,T-cell surface antigen T6/Leu-6,hTa1 thymocyte antigen
En la tabla siguiente se muestra una comparativa de todos los reactivos disponibles en nuestro catálogo (Proteins and Peptides, Primary Antibodies, ELISA Kits) relacionados con CD1A - CD1a molecule
Se muestran ordenados por categorías para poder comparar cómodamente sus características principales. Esta tabla, que contiene un enlace con la ficha de cada producto, es exportable a Excel.
Esta página contiene 34 reactivos de las marcas (Abbexa, FineTest) que se corresponden con tu busqueda
Contacta con nosotros en info@markelab.com, si necesitas mas informacion o alguna aclaracion. Te garantizamos respuesta en menos de 24 h.
provider | Code | reference | name | reactivity | sample type | assay type | test range | sensitivity | price | size 1 | uniprot id | status |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbexa | CD1A | abx386383 | Human T-Cell Surface Glycoprotein CD1a (CD1A) ELISA Kit | Human | Tissue homogenates,Cell lysates,Other biological fluids | Sandwich | 0.156 ng/ml - 10 ng/ml | < 0.06 ng/ml | 687.5 | 96 tests | P06126 | RUO |
provider | Code | reference | name | reactivity | clonality | host | immunogen target | isotype | conjugation | tested applications | price | size 1 | uniprot id | status |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FineTest | CD1A | FNab01435 | anti- CD1A antibody | human | monoclonal | Mouse | CD1a molecule | IgG1 | Unconjugated | ELISA, WB | 100µg | P06126 | RUO | |
FineTest | CD1A | FNab01434 | anti- CD1A antibody | human | polyclonal | Rabbit | CD1a molecule | IgG | Unconjugated | ELISA, WB | 100µg | P06126 | RUO | |
Abbexa | CD1A | abx211317 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Polyclonal | Rabbit | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | ELISA, WB | 250 | 50 µl | P06126 | RUO | |
Abbexa | CD1A | abx139083 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody (FITC) | Human | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | FITC | FCM | 350 | 100 tests | P06126 | RUO | |
Abbexa | CD1A | abx137038 | T-Cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Monoclonal | Mouse | T-Cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | 487.5 | 0.5 mg | RUO | |||
Abbexa | CD1A | abx139082 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody (APC) | Human | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | APC | FCM | 400 | 100 tests | P06126 | RUO | |
Abbexa | CD1A | abx320639 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Polyclonal | Rabbit | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | ELISA, IHC | 237.5 | 50 µl | P06126 | RUO | |
Abbexa | CD1A | abx111464 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Polyclonal | Rabbit | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | ELISA, WB, IF/ICC | 612.5 | 100 µl | P06126 | RUO | |
Abbexa | CD1A | abx139080 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | IHC-F, FCM | 287.5 | 0.1 mg | P06126 | RUO | |
Abbexa | CD1A | abx229131 | T-Cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Monoclonal | Mouse | T-Cell Surface Glycoprotein CD1a (CD1A) | IgG1 | Unconjugated | FCM | 87.5 | 25 µg | P06126 | RUO |
Abbexa | CD1A | abx027451 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Polyclonal | Rabbit | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | ELISA, WB, IHC | 250 | 80 µl | P06126 | RUO | |
Abbexa | CD1A | abx415548 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | IHC, IF/ICC, FCM | 337.5 | 100 µg | P06126 | RUO | |
Abbexa | CD1A | abx415541 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | IHC, IF/ICC, FCM | 462.5 | 200 µg | P06126 | RUO | |
Abbexa | CD1A | abx415547 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody (FITC) | Human | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | FITC | FCM | 400 | 100 µg | P06126 | RUO | |
Abbexa | CD1A | abx139081 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody (PE) | Human | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | PE | FCM | 400 | 100 tests | P06126 | RUO | |
Abbexa | CD1A | abx146226 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Polyclonal | Rabbit | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | ELISA, WB, IHC | 337.5 | 100 µg | RUO | ||
Abbexa | CD1A | abx227100 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Monoclonal | Rabbit | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | IHC | 275 | 40 µl | P06126 | RUO | |
Abbexa | CD1A | abx229133 | T-Cell Surface Glycoprotein CD1a (CD1A) Antibody (FITC) | Human | Monoclonal | Mouse | T-Cell Surface Glycoprotein CD1a (CD1A) | IgG1 | FITC | FCM | 93.75 | 20 tests | P06126 | RUO |
Abbexa | CD1A | abx229134 | T-Cell Surface Glycoprotein CD1a (CD1A) Antibody (PE) | Human | Monoclonal | Mouse | T-Cell Surface Glycoprotein CD1a (CD1A) | IgG1 | PE | FCM | 100 | 20 tests | P06126 | RUO |
Abbexa | CD1A | abx229135 | T-Cell Surface Glycoprotein CD1a (CD1A) Antibody (APC) | Human | Monoclonal | Mouse | T-Cell Surface Glycoprotein CD1a (CD1A) | IgG1 | APC | FCM | 100 | 20 tests | P06126 | RUO |
Abbexa | CD1A | abx231435 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | ELISA, WB | 350 | 100 µg | P06126 | RUO | |
Abbexa | CD1A | abx015794 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | ELISA, WB, IHC, IF/ICC | 362.5 | 100 µl | P06126 | RUO | |
Abbexa | CD1A | abx415550 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody (PE) | Human | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | PE | FCM | 212.5 | 25 tests | P06126 | RUO | |
Abbexa | CD1A | abx010518 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | ELISA, WB, FCM | 362.5 | 100 µl | P06126 | RUO | |
Abbexa | CD1A | abx229132 | T-Cell Surface Glycoprotein CD1a (CD1A) Antibody (Biotin) | Human | Monoclonal | Mouse | T-Cell Surface Glycoprotein CD1a (CD1A) | IgG1 | Biotin | FCM | 93.75 | 25 µg | P06126 | RUO |
Abbexa | CD1A | abx322311 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Polyclonal | Rabbit | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | ELISA, WB, IHC | 237.5 | 50 µl | P06126 | RUO | |
Abbexa | CD1A | abx231434 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Polyclonal | Rabbit | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | ELISA, WB | 350 | 100 µg | P06126 | RUO | |
Abbexa | CD1A | abx159382 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Human | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | ELISA, IHC | 187.5 | 50 µg | P06126 | RUO | |
Abbexa | CD1A | abx415368 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody (PE) | Pig | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | PE | FCM | 637.5 | 100 µg | Q9XS72 | RUO | |
Abbexa | CD1A | abx415367 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody | Pig | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | Unconjugated | FCM | 362.5 | 100 µg | Q9XS72 | RUO | |
Abbexa | CD1A | abx415366 | T-cell Surface Glycoprotein CD1a (CD1A) Antibody (FITC) | Pig | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1a (CD1A) | FITC | FCM | 562.5 | 100 µg | Q9XS72 | RUO | |
Abbexa | CD1A | abx413840 | T-cell Surface Glycoprotein CD1 (CD1) Antibody | Sheep | Monoclonal | Mouse | T-cell Surface Glycoprotein CD1 (CD1) | Unconjugated | IHC, IF/ICC, FCM, IP | 362.5 | 100 µg | O62848, P80943, Q28565, Q29422 | RUO |
provider | Code | reference | name | origin | expression | host | conjugation | tested applications | price | size 1 | uniprot id | status |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbexa | CD1A | abx680045 | Human T-Cell Surface Glycoprotein CD1a (CD1A) Protein | Human | Recombinant | Insect | Unconjugated | SDS-PAGE | 225 | 1 µg | RUO |
Te recomendamos que si no encuentras lo que buscas, utilices el buscador, refinando la búsqueda según tu criterio y usando Alias, o bien contacta con nosotros.